UA106465C2 - Oxyntomodulin peptide analogue - Google Patents

Oxyntomodulin peptide analogue

Info

Publication number
UA106465C2
UA106465C2 UAA201207075A UAA201207075A UA106465C2 UA 106465 C2 UA106465 C2 UA 106465C2 UA A201207075 A UAA201207075 A UA A201207075A UA A201207075 A UAA201207075 A UA A201207075A UA 106465 C2 UA106465 C2 UA 106465C2
Authority
UA
Ukraine
Prior art keywords
peptide analogue
oxyntomodulin peptide
oxyntomodulin
analogue
obesity
Prior art date
Application number
UAA201207075A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Хорхе Алсина-Фернандес
Уэйн Дэйвид Кон
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Priority claimed from PCT/US2010/060390 external-priority patent/WO2011087672A1/en
Publication of UA106465C2 publication Critical patent/UA106465C2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention provides an Oxyntomodulin peptide analogue useful in the treatment of diabetes and/or obesity.
UAA201207075A 2009-12-22 2010-12-15 Oxyntomodulin peptide analogue UA106465C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28888809P 2009-12-22 2009-12-22
PCT/US2010/060390 WO2011087672A1 (en) 2009-12-22 2010-12-15 Oxyntomodulin peptide analogue

Publications (1)

Publication Number Publication Date
UA106465C2 true UA106465C2 (en) 2014-08-26

Family

ID=52681863

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201207075A UA106465C2 (en) 2009-12-22 2010-12-15 Oxyntomodulin peptide analogue

Country Status (1)

Country Link
UA (1) UA106465C2 (en)

Similar Documents

Publication Publication Date Title
TN2012000302A1 (en) Oxyntomodulin peptide analogue
TN2012000303A1 (en) Oxyntomodulin peptide analogue
GEP20146056B (en) Acylated glucagon analogues
UA104605C2 (en) Glucagon analogues
GB2465677B (en) Non-systemic delivery of satiogens for use in the treatment of obesity and/or diabetes
MY158325A (en) Multitype peptide compositions and methods for treatment or prevention of human papillpmavirus infection
EP3593802A3 (en) Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
MX356282B (en) Compositions and methods comprising protease variants.
MX355543B (en) Peptidomimetic macrocycles.
MX2012001346A (en) Modified factor ix polypeptides and uses thereof.
MX338336B (en) Modified insulin polypeptides and their uses.
AU2007221366A8 (en) Oxyntomodulin derivatives
MX2010006823A (en) Methods for the treatment of gout.
ZA200800464B (en) Peptides for use in the treatment of obesity
MX2012009748A (en) Use of transforming growth factor - beta 1 (tgf-î²1) inhibitor peptides for the treatment of corneal fibrosis and/or haze.
MX344166B (en) Modified leptin polypeptides and their uses.
JO3635B1 (en) Solid pharmaceutical compositions and processes for their production
EP2340258A4 (en) Methods for synthesis and uses of inhibitors of ghrelin o-acyltransferase as potential therapeutic agents for obesity and diabetes
EP2318429A4 (en) Prominin-1 peptide fragments and uses thereof
WO2009128867A3 (en) Recombinant biologically contained filovirus
MX2010002950A (en) Methods and compositions for detection of ehrlichia chaffeensis (vlpt).
MX2010005915A (en) Phenyl-oxetanyl-derivatives.
IN2012DN00928A (en)
UA106465C2 (en) Oxyntomodulin peptide analogue
ECSP12011991A (en) OXINTOMODULIN PEPTIDE ANALOG